William R. Markesbery

William R. Markesbery's AcademicInfluence.com Rankings

Philosophy

#3331

World Rank

#5401

Historical Rank

Logic

#1091

World Rank

#1735

Historical Rank

philosophy Degrees

Download Badge

Philosophy

William R. Markesbery's Degrees

Doctorate Medicine University of Kentucky

Why Is William R. Markesbery Influential?

(Suggest an Edit or Addition)

(See a Problem?)

William R. Markesbery's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A randomized trial of surgery in the treatment of single metastases to the brain. (1990) (2807)
Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. (1997) (2324)
Copper, iron and zinc in Alzheimer's disease senile plaques (1998) (1854)
Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. (1998) (1726)
Oxidative stress hypothesis in Alzheimer's disease. (1997) (1663)
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. (1991) (1335)
Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study. (1996) (1026)
Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses (2004) (987)
A Role for 4‐Hydroxynonenal, an Aldehydic Product of Lipid Peroxidation, in Disruption of Ion Homeostasis and Neuronal Death Induced by Amyloid β‐Peptide (1997) (793)
Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation (1995) (790)
Oxidative Alterations in Alzheimer's Disease (1999) (768)
Impaired Proteasome Function in Alzheimer's Disease (2000) (767)
Brain Infarction and the Clinical Expression of Alzheimer Disease-Reply (1997) (682)
Four-Hydroxynonenal, a Product of Lipid Peroxidation, is Increased in the Brain in Alzheimer’s Disease (1998) (655)
Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease (1995) (640)
Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease (2009) (621)
Neurotrophic Factors Attenuate Glutamate‐Induced Accumulation of Peroxides, Elevation of Intracellular Ca2+ Concentration, and Neurotoxicity and Increase Antioxidant Enzyme Activities in Hippocampal Neurons (1995) (618)
Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase‐related protein 2, α‐enolase and heat shock cognate 71 (2002) (600)
Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. (2002) (559)
Alzheimer neuropathologic alterations in aged cognitively normal subjects. (1999) (543)
Proteomic identification of nitrated proteins in Alzheimer's disease brain (2003) (531)
Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress (1996) (526)
Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer's disease (2001) (522)
Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship (2009) (511)
Electrochemical Analysis of Protein Nitrotyrosine and Dityrosine in the Alzheimer Brain Indicates Region-Specific Accumulation (1998) (501)
Increased Nuclear DNA Oxidation in the Brain in Alzheimer's Disease (1998) (478)
Neuropathologic substrate of mild cognitive impairment. (2006) (471)
The glial glutamate transporter, GLT‐1, is oxidatively modified by 4‐hydroxy‐2‐nonenal in the Alzheimer's disease brain: the role of Aβ1–42 (2001) (468)
Acrolein is increased in Alzheimer’s disease brain and is toxic to primary hippocampal cultures (2001) (426)
Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease (2007) (425)
Lipid peroxidation in aging brain and Alzheimer's disease. (2002) (424)
Formation of Isoprostane-like Compounds (Neuroprostanes) in Vivo from Docosahexaenoic Acid* (1998) (419)
Regional Membrane Phospholipid Alterations in Alzheimer's Disease (2004) (405)
Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: Findings from the Nun Study (2002) (405)
Elevated 4-Hydroxynonenal in Ventricular Fluid in Alzheimer’s Disease (1997) (397)
Protein modification by the lipid peroxidation product 4‐hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients (1998) (374)
Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer's disease (2006) (363)
Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease (2006) (358)
Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach (2006) (356)
p38 Kinase Is Activated in the Alzheimer's Disease Brain (1999) (355)
Ribosome Dysfunction Is an Early Event in Alzheimer's Disease (2005) (346)
Cerebrovascular Pathology and Dementia in Autopsied Honolulu‐Asia Aging Study Participants (2002) (343)
Hippocampal volume as an index of Alzheimer neuropathology: Findings from the Nun Study (2002) (324)
Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: An approach to understand pathological and biochemical alterations in AD (2006) (321)
TDP‐43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations (2007) (316)
Age and gender effects on human brain anatomy: A voxel-based morphometric study in healthy elderly (2007) (299)
Oxidative Modification of Creatine Kinase BB in Alzheimer’s Disease Brain (2000) (295)
The role of oxidative stress in Alzheimer disease. (1999) (291)
Increased DNA Oxidation and Decreased Levels of Repair Products in Alzheimer's Disease Ventricular CSF (1999) (290)
Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease (1990) (283)
Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease (1998) (283)
Head Circumference, Education and Risk of Dementia: Findings from the Nun Study (2003) (280)
Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun study. (2000) (280)
Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain. (1998) (280)
Clinicopathologic Correlations in a Large Alzheimer Disease Center Autopsy Cohort: Neuritic Plaques and Neurofibrillary Tangles "Do Count" When Staging Disease Severity (2007) (266)
Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment (2005) (265)
Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study (2005) (256)
Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment (2006) (256)
Defective DNA base excision repair in brain from individuals with Alzheimer's disease and amnestic mild cognitive impairment (2007) (255)
Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis (2006) (254)
Elevated CSF prostaglandin E2 levels in patients with probable AD. (1999) (250)
Possible involvement of proteasome inhibition in aging: implications for oxidative stress (2000) (250)
Decrease in Peptide Methionine Sulfoxide Reductase in Alzheimer's Disease Brain (1999) (248)
Redox proteomic identification of 4-Hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: Insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease (2008) (244)
Regional brain trace-element studies in Alzheimer's disease. (1988) (244)
Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid β-peptide and the membrane lipid peroxidation product 4-hydroxynonenal (2008) (237)
Critical decline in fine motor hand movements in human aging. (1999) (235)
AD lesions and infarcts in demented and non‐demented Japanese‐American men (2005) (231)
Cortical biopsy in Alzheimer's disease: Diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations (1992) (231)
Oxidative damage in mild cognitive impairment and early Alzheimer's disease (2007) (229)
Parkinsonian signs and substantia nigra neuron density in decendents elders without PD (2004) (228)
Low sensitivity in clinical diagnoses of dementia with Lewy bodies (2010) (227)
Brain trace element concentrations in aging (1984) (225)
Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: Implications for the role of nitration in the progression of Alzheimer's disease (2007) (217)
Novel Ubiquitin Neuropathology in Frontotemporal Dementia With Valosin-Containing Protein Gene Mutations (2006) (212)
Neuropathologic alterations in mild cognitive impairment: a review. (2010) (210)
Treatment for patients with cerebral metastases. (1978) (210)
Relationship of lymphocyte invasion and survival of brain tumor patients (1978) (209)
Brain trace elements in Alzheimer's disease. (1986) (208)
Modeling the Association between 43 Different Clinical and Pathological Variables and the Severity of Cognitive Impairment in a Large Autopsy Cohort of Elderly Persons (2010) (203)
Brain Aging and Midlife Tofu Consumption (2000) (197)
Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD (2009) (192)
Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's disease brain. (2000) (191)
Association of olfactory dysfunction with incidental Lewy bodies (2006) (190)
Tau gene mutation in familial progressive subcortical gliosis (1999) (184)
Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3. (2005) (184)
Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease. (2001) (175)
Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment. (2007) (171)
Trace element imbalances in isolated subcellular fractions of Alzheimer's disease brains (1990) (169)
Risk factors for transitions from normal to mild cognitive impairment and dementia (2006) (169)
Decreased base excision repair and increased helicase activity in Alzheimer's disease brain (2000) (168)
Omega-3 fatty acids: potential role in the management of early Alzheimer’s disease (2010) (166)
4‐Hydroxy‐2‐Nonenal Pyrrole Adducts in Human Neurodegenerative Disease (1997) (164)
Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease. (2010) (161)
Human cerebral neuropathology of Type 2 diabetes mellitus. (2009) (161)
β-Amyloid Is Different in Normal Aging and in Alzheimer Disease* (2005) (160)
Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid. (2001) (158)
Recent Clinical-Pathologic Research on the Causes of Dementia in Late Life: Update From the Honolulu-Asia Aging Study (2005) (156)
Lewy Body Pathology in Normal Elderly Subjects (2009) (154)
Intraputamenal infusion of GDNF in aged rhesus monkeys: Distribution and dopaminergic effects (2003) (144)
DNA oxidation in Alzheimer's disease. (2006) (144)
Brain structural alterations before mild cognitive impairment (2007) (144)
Hypothalamic-immune interactions. I. The acute effect of anterior hypothalamic lesions on the immune response (1980) (144)
Linguistic Ability in Early Life and the Neuropathology of Alzheimer's Disease and Cerebrovascular Disease: Findings from the Nun Study (2000) (142)
4-Hydroxynonenal, a Product of Lipid Peroxidation, Damages Cholinergic Neurons and Impairs Visuospatial Memory in Rats (1998) (138)
White matter volumes and periventricular white matter hyperintensities in aging and dementia (2000) (133)
Reoperation for glioblastoma. (1981) (127)
Decreased RNA, and Increased RNA Oxidation, in Ribosomes from Early Alzheimer’s Disease (2006) (126)
Laser microprobe analysis of brain aluminum in Alzheimer' disease (1993) (125)
The Nun Study (2009) (124)
Late onset hereditary distal myopathy (1974) (123)
β-Amyloid Mediated Nitration of Manganese Superoxide Dismutase: Implication for Oxidative Stress in a APPNLh/NLh X PS-1P264L/P264L Double Knock-In Mouse Model of Alzheimer's Disease (2006) (123)
Hypothalamic-immune interactions: neuromodulation of natural killer activity by lesioning of the anterior hypothalamus. (1984) (122)
Proteomic identification of nitrated brain proteins in early Alzheimer’s disease inferior parietal lobule (2009) (121)
Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures. (2000) (120)
Identification and characterization of OGG1 mutations in patients with Alzheimer's disease (2007) (118)
Elemental imbalances in the olfactory pathway in Alzheimer's disease (1995) (117)
Reactive Oxygen Species as Causal Agents in the Neurotoxicity of the Alzheimer's Disease‐Associated Amyloid Beta Peptide a (1996) (115)
The Nitration Product 5-Nitro-γ-tocopherol Is Increased in the Alzheimer Brain (2002) (115)
The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients. (1999) (115)
Progression of regional neuropathology in Alzheimer disease and normal elderly: findings from the Nun study. (1999) (110)
Altered serotonergic and cholinergic synaptic markers in Pick's disease. (1991) (109)
Hereditary carnitine deficiency of muscle (1975) (107)
AD brain pathology: Vascular origins? Results from the HAAS autopsy study (2008) (107)
The expression of key oxidative stress-handling genes in different brain regions in alzheimer’s disease (1998) (107)
Mutations in amyloid precursor protein and presenilin‐1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid β‐peptide (1–42), H2O2 and kainic acid: implications for Alzheimer's disease (2006) (106)
Iron, selenium and glutathione peroxidase activity are elevated in sporadic motor neuron disease (1994) (105)
Association between male gender and cortical Lewy body pathology in large autopsy series (2010) (105)
Hypothalamic-immune interactions Effect of hypophysectomy on neuroimmunomodulation (1982) (105)
Altered 8-oxoguanine glycosylase in mild cognitive impairment and late-stage Alzheimer's disease brain. (2008) (104)
Oxidative stress in head trauma in aging. (2006) (104)
Comparison of Neuropathologic Criteria for the Diagnosis of Alzheimer’s Disease (1997) (103)
Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models. (2008) (102)
Influence of serotonin on the immune response. (1985) (102)
F2-isoprostanes in Alzheimer and other neurodegenerative diseases. (2005) (100)
Alzheimer disease pathology in cognitively healthy elderly: A genome-wide study (2011) (100)
Healthy ageing in the Nun Study: definition and neuropathologic correlates. (2007) (99)
Protection against amyloid beta peptide toxicity by zinc (1999) (98)
Associations of cortical astrogliosis with cognitive performance and dementia status. (2005) (98)
Oxidatively modified RNA in mild cognitive impairment (2008) (97)
Alzheimer's disease, dental amalgam and mercury. (1999) (96)
Association of HFE mutations with neurodegeneration and oxidative stress in Alzheimer's disease and correlation with APOE (2003) (96)
Methodological Considerations in Studying Centenarians: Lessons Learned From the Georgia Centenarian Studies (2007) (96)
Neuroimmunomodulation: Neural anatomical basis for impairment and facilitation (1982) (95)
The Expression of Several Mitochondrial and Nuclear Genes Encoding the Subunits of Electron Transport Chain Enzyme Complexes, Cytochrome c Oxidase, and NADH Dehydrogenase, in Different Brain Regions in Alzheimer's Disease (1999) (95)
Brains With Medial Temporal Lobe Neurofibrillary Tangles But No Neuritic Amyloid Plaques Are a Diagnostic Dilemma But May Have Pathogenetic Aspects Distinct From Alzheimer Disease (2009) (94)
Survival of hippocampal and cortical neurons in a mixture of MEM+ and B27-supplemented neurobasal medium. (2000) (92)
Brain aluminum in Alzheimer's disease using an improved GFAAS method. (1992) (91)
Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease (2010) (91)
Elevated manganese levels associated with dementia and extrapyramidal signs (1977) (91)
Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer's disease: insights into memory loss in MCI. (2011) (89)
Postoperative Radiotherapy in the Treatment of Single Metastases to the Brain (1998) (89)
NOX activity is increased in mild cognitive impairment. (2010) (89)
Expression and Activities of Aldo‐Keto Oxidoreductases in Alzheimer Disease (2001) (89)
Altered expression of zinc transporters-4 and -6 in mild cognitive impairment, early and late Alzheimer’s disease brain (2006) (88)
Neuroanatomic and neurotransmitter influences on immune function. (1985) (87)
Hypothalamic-immune interactions. II. The effect of hypothalamic lesions on the ability of adherent spleen cells to limit lymphocyte blastogenesis. (1982) (86)
Seven cases of cerebromedullospinal disconnection (1971) (86)
Evidence that γ-secretase mediates oxidative stress-induced β-secretase expression in Alzheimer's disease (2010) (86)
beta-amyloid is different in normal aging and in Alzheimer disease. (2005) (86)
Preclinical Alzheimer disease: Brain oxidative stress, Aβ peptide and proteomics (2010) (85)
Neuropathological Criteria for the Diagnosis of Alzheimer’s Disease (1997) (84)
Neprylisin decreases uniformly in Alzheimer's disease and in normal aging (2005) (84)
Familial progressive subcortical gliosis (1995) (84)
Muscle carnitine deficiency. Association with lipid myopathy, vacuolar neuropathy, and vacuolated leukocytes. (1974) (84)
Fatal adenovirus meningoencephalitis in a bone marrow transplant patient (1988) (83)
Oxidative lipid modification of nicastrin enhances amyloidogenic γ‐secretase activity in Alzheimer’s disease (2012) (83)
Protection against amyloid beta peptide and iron/hydrogen peroxide toxicity by alpha lipoic acid. (2003) (83)
Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage alzheimer’s disease (2009) (83)
Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age. (2008) (83)
Neuroimmunomodulation: impairment of humoral immune responsiveness by 6-hydroxydopamine treatment. (1986) (82)
Brain donation in normal aging: procedures, motivations, and donor characteristics from the Biologically Resilient Adults in Neurological Studies (BRAiNS) Project. (2001) (81)
Autoantibodies to amyloid β-peptide (Aβ) are increased in Alzheimer’s disease patients and Aβ antibodies can enhance Aβ neurotoxicity (2007) (81)
Kalirin is under-expressed in Alzheimer's disease hippocampus. (2007) (78)
Potential in vivo amelioration by N‐acetyl‐L‐cysteine of oxidative stress in brain in human double mutant APP/PS‐1 knock‐in mice: Toward therapeutic modulation of mild cognitive impairment (2010) (78)
Relative preservation of MMSE scores in autopsy-proven dementia with Lewy bodies (2009) (77)
Glutathione transferase protects neuronal cultures against four hydroxynonenal toxicity. (1998) (77)
Delayed recall, hippocampal volume and Alzheimer neuropathology (2004) (76)
Elevated 4-hydroxyhexenal in Alzheimer's disease (AD) progression (2012) (76)
Memory complaints in nondemented men predict future pathologic diagnosis of Alzheimer disease (2004) (75)
Distal myopathy (1977) (75)
Laminar organization of cholinergic circuits in human frontal cortex in Alzheimer's disease and aging (1985) (74)
Oxidized Low‐Density Lipoprotein Induces Neuronal Death (1999) (74)
Hypothalamic astrocytoma. Syndrome of hyperphagia, obesity, and disturbances of behavior and endocrine and autonomic function. (1983) (72)
Early descriptions of the Arnold-Chiari malformation. The contribution of John Cleland. (1972) (72)
Alzheimer's-type neuropathology in the precuneus is not increased relative to other areas of neocortex across a range of cognitive impairment (2009) (71)
Aβ solubility and deposition during AD progression and in APP×PS-1 knock-in mice (2007) (70)
Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH/NLH X PS-1P264L/P264L double knock-in mouse model of Alzheimer's disease. (2006) (70)
Organoselenium (Sel-Plex diet) decreases amyloid burden and RNA and DNA oxidative damage in APP/PS1 mice. (2009) (69)
Histological features of congenital lipomas of the lower spinal canal. (1980) (69)
Spin label and biochemical studies of erythrocyte membranes in Alzheimer's disease (1980) (68)
4-Hydroxynonenal oxidatively modifies histones: implications for Alzheimer's disease (2004) (68)
Neuropathology of dementing disorders (1998) (68)
Carboxy terminal of β-amyloid deposits in aged human, canine, and polar bear brains (1996) (64)
Expression of p53, bcl-2, E-cadherin, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinases-1 in paired primary tumors and brain metastasis. (1999) (63)
Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene. (2005) (63)
CD36 overexpression in human brain correlates with beta-amyloid deposition but not with Alzheimer's disease. (2004) (63)
MRI Temporal Lobe Volume Measures and Neuropsychologic Function in Alzheimer's Disease (1999) (63)
Recurrent hemichorea following striatal lesions. (1974) (63)
Genetic and Expression Profiles of Cerebellar Liponeurocytomas (2004) (61)
Seleno-L-methionine protects against beta-amyloid and iron/hydrogen peroxide-mediated neuron death. (2007) (59)
Brain manganese concentrations in human aging and Alzheimer's disease. (1984) (59)
Trace element content in fingernails and hair of a nonindustrialized US control population (1988) (58)
Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain (2009) (58)
Understanding dementia prevalence among centenarians. (2012) (56)
The nitration product 5-nitro-gamma-tocopherol is increased in the Alzheimer brain. (2002) (55)
Serum zinc levels and Alzheimer’s disease (2007) (55)
Quantitative Proteomic Analysis of Mitochondria from Primary Neuron Cultures Treated with Amyloid Beta Peptide (2004) (54)
Specificity of biophysical and biochemical alterations in erythrocyte membranes in neurological disorders Huntington's disease, Friedreich's ataxia, Alzheimer's disease, amyotrophic lateral sclerosis, and myotonic and Duchenne muscular dystrophy (1980) (53)
Serum zinc in the progression of Alzheimer's disease. (2008) (53)
Elevation of AKR7A2 (succinic semialdehyde reductase) in neurodegenerative disease (2001) (53)
Amyloid β‐Peptide Effects on Synaptosomes from Apolipoprotein E‐Deficient Mice (2000) (52)
Expression of glutathione-S-transferase isozyme in the SY5Y neuroblastoma cell line increases resistance to oxidative stress. (2001) (52)
Review of 38 cases of subacute sclerosing panencephalitis: Effect of amantadine on the natural course of the disease (1980) (51)
Aging in a dish: Age‐dependent changes of neuronal survival, protein oxidation, and creatine kinase BB expression in long‐term hippocampal cell culture (1999) (50)
Abeta solubility and deposition during AD progression and in APPxPS-1 knock-in mice. (2007) (50)
Lipidized medulloblastoma in adults. (1993) (50)
Designing a large prevention trial: statistical issues (2004) (49)
Elevated Zinc Transporter-6 in Mild Cognitive Impairment, Alzheimer Disease, and Pick Disease (2006) (48)
Isolation of neural precursor cells from Alzheimer's disease and aged control postmortem brain (2006) (48)
Suppression of essential tremor by propranolol: Correlation of effect with drug plasma levels and intensity of beta‐adrenergic blockade (1977) (47)
Autoantibodies to amyloid beta-peptide (Abeta) are increased in Alzheimer's disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine development. (2003) (47)
Arteriovenous shunts in the blood supply to the brains of some common laboratory animals—with special attention to the rete mirabile conjugatum in the cat (1963) (46)
Under-expression of Kalirin-7 Increases iNOS activity in cultured cells and correlates to elevated iNOS activity in Alzheimer's disease hippocampus. (2007) (46)
Serum zinc, senile plaques, and neurofibrillary tangles: findings from the Nun Study. (1995) (45)
Proteomic analysis of brain proteins in APP/PS‐1 human double mutant knock‐in mice with increasing amyloid β‐peptide deposition: Insights into the effects of in vivo treatment with N‐acetylcysteine as a potential therapeutic intervention in mild cognitive impairment and Alzheimer's disease (2011) (45)
Selective loss of KGDHC-enriched neurons in alzheimer temporal cortex (2001) (45)
Temporal relations among amyloid β-peptide-induced free-radical oxidative stress, neuronal toxicity, and neuronal defensive responses (1998) (45)
3α,5α-THP: a potential plasma neurosteroid biomarker in Alzheimer's disease and perhaps non-Alzheimer's dementia (2006) (44)
Alzheimer's disease. Aminergic-cholinergic alterations in hypothalamus. (1988) (44)
Lactic acidemia, mitochondrial myopathy, and basal ganglia calcification (1979) (44)
Apolipoprotein E allelic influence on human cerebrospinal fluid apolipoproteins. (1998) (44)
Scanning electron microscopy studies of erythrocytes in Huntington's disease. (1977) (43)
Molecular changes in brain aging and Alzheimer's disease are mirrored in experimentally silenced cortical neuron networks (2012) (43)
Electron microscopic findings in primitive neuroectodermal tumors of the cerebrum (1979) (43)
Neuron specific toxicity of oligomeric amyloid-β: role for JUN-kinase and oxidative stress. (2010) (43)
Familial progressive subcortical gliosis (1994) (43)
Intracranial ependymoma: Results of radiotherapy at the University of Kentucky (1982) (43)
Familial influence on plaque formation in the beagle brain. (1992) (42)
Comparison of the effects of elevated intracellular aluminum and calcium levels on neuronal survival and tau immunoreactivity (1993) (42)
Proteomic identification of specifically carbonylated brain proteins in APP(NLh)/APP(NLh) × PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice model of Alzheimer disease as a function of age. (2011) (41)
Trace element correlations with age and sex in human fingernails (1995) (41)
Age-related loss of phospholipid asymmetry in APP NLh /APP NLh x PS-1 P264L /PS-1 P264L human double mutant knock-in mice: Relevance to Alzheimer disease (2010) (40)
Monoaminergic and cholinergic synaptic markers in the nucleus basalis of meynert (nbM): Normal age‐related changes and the effect of heart disease and Alzheimer's disease (1992) (40)
Expression of microsomal epoxide hydrolase is elevated in Alzheimer's hippocampus and induced by exogenous β‐amyloid and trimethyl‐tin (2006) (40)
Fatal neonatal nemaline myopathy with multiple congenital anomalies. (1979) (40)
Clinical Features of Mild Cognitive Impairment Differ in the Research and Tertiary Clinic Settings (2008) (40)
Trace element imbalances in amyotrophic lateral sclerosis. (1990) (39)
The Effect of APOE-ϵ4 on Dementia is Mediated by Alzheimer Neuropathology (2009) (38)
Trace elements in Alzheimer's disease pituitary glands (1998) (38)
Alterations in brain monoamine oxidase activity in aging, Alzheimer's disease, and Pick's disease. (1991) (38)
An automated technique for measuring hippocampal volumes from MR imaging studies. (2001) (37)
Neutron activation analysis of trace elements in motor neuron disease spinal cord. (1995) (36)
Huntington's disease: a generalized membrane defect. (1981) (36)
Trace element imbalances in hair and nails of Alzheimer's disease patients. (1988) (36)
Quantitative changes in the mitochondrial proteome from subjects with mild cognitive impairment, early stage, and late stage Alzheimer's disease. (2010) (36)
Wilms’ tumor suppressor (WT1) is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer’s disease (2003) (35)
Late-infantile neuronal ceroid-lipofuscinosis. An ultrastructural study of lymphocyte inclusions. (1976) (35)
The effect of APOE-epsilon4 on dementia is mediated by Alzheimer neuropathology. (2009) (34)
Cyclic nucleotides attenuate lipid peroxidation‐mediated neuron toxicity (1998) (34)
31P magnetic resonance spectroscopy in alzheimer's and pick's disease (1993) (34)
Familial progressive external ophthalmoplegia and ragged‐red fibers (1974) (34)
An aberrant protein complex in CSF as a biomarker of Alzheimer disease (2008) (32)
Human Fetal Cerebellar Cortex: Organization and Maturation of Cells in vitro (1971) (32)
Amyloid beta peptide, 4-hydroxynonenal and apoptosis. (2006) (32)
Methyl bromide intoxication (1977) (32)
Electron spin resonance, hematological, and deformability studies of erythrocytes from patients with Huntington's disease. (1979) (31)
Cytoskeletal Neurofilament Gene Expression in Brain Tissue from Alzheimer's Disease Patients. I. Decrease in NF-L and NF-M Message (1994) (31)
Use of bomb pulse carbon-14 to age senile plaques and neurofibrillary tangles in Alzheimer’s disease (2002) (30)
Cerebral mass due to sarcoidosis (1973) (30)
Acetylcholinesterase inhibitor treatment is associated with relatively slow cognitive decline in patients with Alzheimer's disease and AD + DLB. (2009) (28)
Comparison of Recruitment Efforts Targeted at Primary Care Physicians Versus the Community at Large for Participation in Alzheimer Disease Clinical Trials (2010) (27)
Infratentorial neuroepithelial cyst (colloid cyst). Case report. (1978) (26)
A CORRELATED LIGHT AND ELECTRON MICROSCOPIC STUDY OF THE EARLY PHASE OF GROWTH IN VITRO OF HUMAN FETAL CEREBELLAR AND CEREBRAL CORTEX (1974) (25)
Laser Microprobe Mass Spectrometric Study of Aluminum and Silicon in Brain Emboli Related to Cardiac Surgery (1998) (25)
Ultrastructure of pineal parenchymal neoplasms (2004) (25)
RNAA for arsenic, cadmium, copper, and molybdenum in CNS tissues from subjects with age-related neurodegenerative diseases (1994) (24)
Oxidative Alterations in Neurodegenerative Diseases (2001) (24)
NEURONAL INTRACYTOPLASMIC HYALINE INCLUSIONS (1971) (23)
Erythrocyte membrane alterations in Huntington disease: Effects of γ‐aminobutyric acid (1978) (22)
Evidence for a membrane surface defect in erythrocytes in Huntington's disease. (1980) (22)
Ectopic Expression of Musashi-1 in Alzheimer Disease and Pick Disease (2005) (22)
Alzheimer's disease and head circumference. (2006) (20)
Increased protein hydrophobicity in response to aging and Alzheimer disease. (2010) (20)
Characterization of Japanese-American men with a single neocortical AD lesion type (2008) (19)
182 BRAIN TRACE ELEMENT LEVELS IN ALZHEIMERʼS DISEASE BY INSTRUMENTAL NEUTRON ACTIVATION ANALYSIS (1981) (19)
Increased chloride transport in erythrocytes in Huntington's disease. (1980) (19)
Trace metals in human neurodegenerative diseases. (1993) (19)
Mucopolysaccharidoses: Ultrastructure of leukocyte inclusions (1980) (19)
Traumatic carotid-cavernous fistula with fatal epistaxis. Report of a case. (1966) (19)
Quantitation in laser microprobe mass spectrometry (LMMS) as applied to biological tissue analysis (1992) (18)
Effects of chronic denervation on the histology of canine extraocular muscle. (1982) (18)
Small Head Circumference is Associated With Less Education in Persons at Risk for Alzheimer Disease in Later Life (2008) (18)
Iodine-123 HIPDM brain imaging findings in subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). (1987) (18)
Opposing Actions of Native and Oxidized Lipoprotein on Motor Neuron-like Cells (1999) (18)
Spin label studies of human erythrocyte membranes in aging. (1982) (17)
Arnold-Chiari malformation in an elderly woman. (1969) (16)
Quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease. (2001) (16)
3alpha,5alpha-THP: a potential plasma neurosteroid biomarker in Alzheimer's disease and perhaps non-Alzheimer's dementia. (2006) (15)
Increased 5S rRNA oxidation in Alzheimer's disease. (2012) (15)
Transplantation of pituitary grafts fail to restore immune function and to reconstitute the thymus glands of aged mice (1990) (15)
Morphometric image analysis of neuropil threads in alzheimer's disease (1993) (15)
Urban‐Rural Differences in a Memory Disorders Clinical Population (2001) (15)
Age-associated alteration of serotonergic synaptic neurochemistry in rat rostral hypothalamus (1985) (14)
General immunocompetence of rats bearing avian sarcoma virus-induced intracranial tumors. (1978) (14)
Determination of aluminium in human brain tissue by electrothermal atomic absorption spectrometry (1992) (14)
Regional levels of brain phospholipase Cγ in Alzheimer's disease (1998) (13)
Disruption of zinc homeostasis in Alzheimer's disease (2002) (12)
Standardization in biological analyses of aluminum: what are the needs? (1996) (12)
Presence of neuronal proteins in serially cultured cells from autopsy human brain (1994) (12)
Invasiveness in primary intracranial tumors: Part 1. An experimental model using cloned SV40 virus-produced hamster brain tumors. (1986) (12)
Apolipoprotein E genotypes in AA and AL amyloidoses (1995) (12)
A search for longitudinal variations in trace element levels in nails of Alzheimer’s disease patients (1990) (12)
Diencephalic syndrome. Long-term survival. (1973) (11)
Ultrastructural observations of the myenteric plexus of the pylorus in infantile hypertrophic pyloric stenosis. (1977) (11)
Neuronal RNA in Pick's and Alzheimer's diseases. Comparison of disease-susceptible and disease-resistant cortical areas. (1989) (11)
NEOMATAL BETA-GLUCURONIDASE-DEFICIENCY MUCOPOLYSACCHARIDOSIS (MPS VII): AUTOPSY FINDINGS (1982) (11)
Effects of short-term Western diet on cerebral oxidative stress and diabetes related factors in APP × PS 1 knockin mice (2009) (11)
Metabolic implications of distal atrophy Carbohydrate metabolism in centronuclear myopathy (1978) (11)
QUANTITATION OF ARGYROPHILIC GRAINS IN HIPPOCAMPAL CA-1 OF AGED JAPANESE-AMERICAN MEN (1997) (11)
Sensitivity improvements in the determination of mercury in biological tissues by neutron activation analysis (1995) (10)
Lead determinations in human bone by particle induced X-ray emission (PIXE) and graphite furnace atomic absorption spectrometry (GFAAS) (1995) (10)
Congenital myopathy and cardiomyopathy with identical ultrastructural changes. (1990) (9)
Trace Elements in Dementing Disorders (1988) (9)
Cerebellar glioblastoma in childhood (2004) (9)
Evidence for an Altered Physical State of Membrane Proteins in Erythrocytes in Friedreich's Ataxia (1979) (9)
APOε2 and education in cognitively normal older subjects with high levels of AD pathology at autopsy: findings from the Nun Study (2015) (9)
Evidence for an increased rate of choline efflux across erythrocyte membranes in Alzheimer's disease (1985) (9)
Antioxidants for the prevention of dementia: Overview of the preadvise trial (2005) (9)
Ion beam analysis of the bone tissue of Alzheimer's disease patients (1992) (8)
Lymphocyte subpopulations and responsiveness in rats bearing intracranial tumors induced by avian sarcoma virus. (1981) (8)
Improved predictive model for pre-symptomatic mild cognitive impairment and Alzheimer's disease (2008) (8)
Comments on vascular dementia. (1991) (8)
Brain reserve and risk of dementia: Findings from the Nun Study (2013) (8)
Regional levels of brain phospholipase Cgamma in Alzheimer's disease. (1998) (8)
BRAAK STAGES III-IV OF ALZHEIMER-RELATED NEUROPATHOLOGY ARE ASSOCIATED WITH MILD MEMORY LOSS, STAGES V-VI ARE ASSOCIATED WITH DEMENTIA: FINDINGS FROM THE NUN STUDY (1996) (8)
The diagnosis of Alzheimer's disease. (1993) (7)
Alzheimer Disease Brain Extract Stimulates Branching of Laminin‐Mediated Neuronal Processes (1992) (7)
Overview of vascular dementia (2000) (7)
Characterization of brain samples in studies of aging, Alzheimer's, and other neurodegenerative diseases (1993) (7)
Trace Elements In Alzheimer’s Disease (1996) (7)
Alzheimer's disease--a mini review. (1989) (7)
Identification and Characterization of OGG 1 Mutations in Patients with Alzheimer ' s Disease (2018) (6)
Applications of neutron activation analysis to the study of age-related neurological diseases (1987) (6)
Biophysical and biochemical characterization of the intrinsic fluorescence from neurofibrillary tangles (2006) (6)
Brain biopsy in cases of neonatal herpes simplex encephalitis. (1985) (6)
Amyloid β-peptide(1–40)-mediated oxidative stress in cultured hippocampal neurons (2007) (5)
THE HYPOTHALAMUS IN SENILE DEMENTIA OF THE ALZHEIMER TYPE (1986) (5)
Use of bomb pulse 14C to age senile plaques and neurofibrillary tangles in the Alzheimer's disease brain (2001) (5)
The Neuropathology of Alzheimer's Disease: Diagnostic Features and Standardization (1996) (5)
Neuromodulation of lymphocyte reactivity in aged rats (1984) (5)
In situ analysis of neostriatal RNA and chromatin in Alzheimer's disease (1987) (5)
NEUROPATHOLOGIC ALTERATIONS IN AGED COGNITIVELY “NORMAL” SUBJECTS (1998) (5)
Time-dependence of, and effects of inhibition and cellular aging on, chloride efflux across erythrocyte membranes in Huntington's disease (1982) (5)
Aluminum in motor neuron disease spinal cord (1997) (5)
Simultaneous determination of P and N in human tissue by 14 MeV neutron activation analysis (1987) (5)
Diet composition and sex influence bioperiodicity in rat's central nervous system histamine (H1) receptors (1998) (5)
Imaging the Centenarian Brain (1985) (4)
Suppression of essential tremor by propranolol: correlation of effect with intensity of beta-adrenergic blockade. (1976) (4)
Effects of repeated screening and potential impact on AD prevention trial design: The antioxidant AD prevention (PREADVISE) trial (2009) (4)
Perivascular hemosiderin deposition in muscle in Waldenström's macroglobulinemia (1975) (4)
Lactic acidosis associated with cerebellar vermal atrophy and cardiomyopathy. (1978) (4)
Spin labeling studies of membrane proteins in erythrocyte ghosts from patients with Huntington's disease (1983) (4)
Alzheimer's Disease: No alteration in the physical state of erythrocyte membrane glycoconjugates (1985) (4)
Benzodiazepine receptors in Huntington's disease (1988) (4)
Trace element correlations between human brain and fingernails (1992) (4)
BIOPHYSICAL STUDIES OF ERYTHROCYTE MEMBRANES IN HUNTINGTON'S DISEASE (1978) (4)
LOCALIZED PICK BODIES. BALLOON CELLS. AND NEOCORTICAL CHANGES OF ALZHEIMER TYPE IN A DEMENTED PATIENT WITH PROGRESSIVE SUPRANUCLEAR PALSY: 32 (1989) (3)
Cf-252 brain implantation for malignant glioma: Experience of the University of Kentucky, Lexington (1986) (3)
THE AMYGDALA IN ALZHEIMERʼS DISEASE, AGING AND CORONARY ARTERY DISEASE; INCIDENCE OF SENILE PLAQUES AND ALTERED CHEMISTRY: 100 (1989) (3)
Nuclear methods of analysis applied to quantitation in laser microprobe mass spectrometry (1992) (3)
Early-life linguistic ability, late-life pathology and asymptomatic Alzheimer's disease: Findings from the Nun Study (2009) (3)
Bone marrow cellularity and Na and K levels in fasting and inanition after bile duct ligation. (1961) (3)
Amyloid b-Peptide Effects on Synaptosomes from Apolipoprotein E-Deficient Mice * (2000) (3)
Analysis of Aldehydic Markers of Lipid Peroxidation in Biological Tissues by HPLC with Fluorescence Detection (2003) (3)
NEURONAL ACCUMULATION OF ALUMINUM IN DIALYSIS ENCEPHALOPATHY - A LASER MICROPROBE STUDY (1995) (3)
Commentary on “Vascular cognitive impairment: Today and tomorrow” (2006) (3)
Erythrocyte membrane alterations in Huntington disease: effects of gamma-aminobutyric acid. (1978) (2)
Application of electron energy loss spectroscopy and electron spectroscopic imaging to aluminum determination in biological tissue (2008) (2)
Perivascular siderophages in skeletal muscle from a patient with diabetic neuropathy (2004) (2)
Specificity of biophysical and biochemical alterations in erythrocyte membranes in neurological diseases: Huntington's disease, Friedreich's ataxia, Alzheimer's disease, amyotrophic lateral sclerosis, and myotonic and Duchenne muscular dystrophy. (1979) (2)
Brain trace element studies of aging and disease by INAA (1982) (2)
A clinical study with brain brachytherapy for malignant gliomas. (1986) (2)
EMULSIFIED PANTOPAQUE FOR CEREBRAL VENTRICULOGRAPHY. (1964) (2)
Role of spontaneous interstitial cell testicular tumors on the mitogen reactivity of spleen cells from aged male fischer-344 rats (1984) (2)
Cerebrospinal fluid lipoprotein delivery to human neuronal cells is increased in Alzheimer's disease and is dependent on apoE monomer concentration. (2002) (2)
THE EFFECT OF HYPOTHALAMIC LESIONS ON NATURAL CYTOTOXIC LYMPHOCYTE ACTIVITY: 19 (1982) (1)
A randomized prospective trial of the benefit of postoperative radiotherapy in the treatment of single metastases to the brain (1998) (1)
Studies of trace element imbalances in Alzheimer's disease using sequential NAA (1986) (1)
CT and MR for brain tumor implant therapy using CF-252 neutrons (2004) (1)
P4-393: Memory screening validation for Alzheimer prevention trials: The prevention of Alzheimer's disease by vitamin E and selenium (PREADVISE) study (2008) (1)
Astrocyte RNA in relation to neuronal RNA depletion in Alzheimer's disease (2004) (1)
The Neuropathology of Alzheimer’s Disease (2019) (1)
Intracerebral neutron brachytherapy for hemispheric glioblastoma multiforme (1984) (1)
COMPUTER IMAGE ANALYSIS OF MIDDLE TEMPORAL GYRUS IN PICKʼS DISEASE: 51 (1990) (1)
Asymptomatic AD is associated with hypertrophy of CA1‐hippocampus neurons in the NUN study (2008) (1)
P4-054: Cerebral cortical atrophy, brain infarcts, and clinical expression of Alzheimer pathology: Findings from The Nun Study (2008) (1)
A malignant glioma therapeutic staging system for Cf-252 neutron brachytherapy at the University of Kentucky (1986) (1)
In situ analysis of neostriatal RNA and chromatin in Alzheimerʼs disease (1988) (1)
O2-04-05 Proteomic analysis of mitochondria from control, early, and late state Alzheimer's disease subjects (2004) (1)
Late-onset sporadic progressive subcortical gliosis (1998) (1)
Apolipoprotein E-ε4 as a risk factor for Alzheimer and non-Alzheimer'sdementias: Findings from the nun study (2000) (1)
In vitro studies of normal newborn rat cerebellum using a chemically defined tissue culture medium. (1971) (1)
Larger head circumference and greater education provide protection against incident dementia independent of the severity of Alzheimer pathology: The Nun Study (2009) (1)
Pathology of muscular dystrophy and related disorders. (1977) (1)
Neurofibrillary tangles, neuritic plaques, and cerebrovascular lesions at death among demented and cognitively normal Japanese-American men (2000) (1)
Neuropathological and memory changes in transitions between normal aging, MCI, and mild Alzheimer’s disease (2005) (0)
Muscle Diseases Due to Disorders of Lipid Metabolism (1983) (0)
P4-128: Aging-related primary brain atrophy: Frequency, association with dementia, and risk factors in the Honolulu-Asia Aging Study (2008) (0)
GLUTAMINE SYNTHETASE IMMUNOHISTOCHEMICAL DISTRIBUTION IN TEMPORAL, PARAHIPPOCAMPAL, PARIETAL AND OCCIPITAL CORTICES IN AD AND CONTROL SUBJECTS: 72 (1995) (0)
O3-04-06 Neuropathological findings according to various trajectories of cognitive decline in the Honolulu-Asia aging study (2006) (0)
117 IMMUNOLOGIC PRIVILEGE IN THE CENTRAL NERVOUS SYSTEM (1983) (0)
Preclinical Alzheimer's disease cannot be reliably identified in the antemortem setting using standard clinical and neuropsychological test measures (2009) (0)
NEURON SPECIFIC TOXICITY OF OLIGOMERIC BETA AMYLOID: Implications for JUN-kinase and oxidative stress (2012) (0)
Neuropathologic confirmation of clinically diagnosed Alzheimers disease The Honolulu-Asia aging study (1999) (0)
Modulation of the immune response by lesions in the anterior hypothalamus (1980) (0)
Textbook of Neuropathology (1991) (0)
Studies of generalized elemental imbalances in neurological disease patients using INAA (instrumental neutron activation analysis) (1988) (0)
Effects of interstitial irradiation on normal brain tissue using Cf-252 or Cs-137 radioactive sources (1984) (0)
P3-159: Practice effects: Factors associated with repeated memory impairment screen scores in the antioxidant Alzheimer's disease prevention (PREADVISE) trial (2008) (0)
SUBCELLULAR TRACE ELEMENT CONCENTRATIONS IN ALZHEIMERʼS DISEASE: 109 (1989) (0)
P1-162: Mild cognitive impairment in two distinct clinical populations: Acceptance of diagnosis, medical causes, and cognitive profiles (2008) (0)
ULTRASTRUJCTURAL STUDY OF CIRCULATING LEUKOCYTES IN NEURONAL STORAGE DISORDERS: 23 (1976) (0)
Clinicopathological correlations in a large Alzheimer's Disease Center autopsy cohort: utility of plaque and tangle counts and application to specific topics. (2008) (0)
Brain Microdissection Techniques (1984) (0)
P1-167 Soluble abeta shows a different composition in normal aging and Alzheimer's disease (2004) (0)
Synaptosomes from apolipoprotein E-deficient mice are vulnerable to oxidative insult from Aβ (2000) (0)
P1-393: Hypertrophy of CA1-hippocampal neurons and APOE frequency in asymptomatic Alzheimer's disease: Findings from the Nun Study (2008) (0)
252CF Neutron brachytherapy for malignant glioma at the University of Kentucky and a malignant glioma therapeutic staging system (1986) (0)
P1-158 Alzheimer’s disease in centenarians: Clinicopathologic correlations in the georgia centenarian study (2006) (0)
Abstracts of the 3rd European Congress of Biogerontology (2004) (0)
Pituitary gland levels of mercury, selenium, iron, and zinc in an Alzheimer`s disease study (1996) (0)
Apolipoprotein composition of human cerebrospinal fluid lipoproteins varies with APOE genotype (1998) (0)
P-118 Concordance of MIS and CERAD screening in the preadvise antioxidant AD prevention trial (2007) (0)
P-049 Lower baseline weight and faster weight loss predict time to develop dement ia in the nun study (2007) (0)
P-200 Factors associated with practice effects and decline in MIS scores in the preadvise antioxidant Alzheimer’s disease prevention trial (2007) (0)
HIPPOCAMPAL NEURONAL RNA IN ALZHEIMERʼS DISEASE (1986) (0)
Application of electron energy loss spectroscopy and electron spectroscopic imaging to aluminum development in biological tissue (2008) (0)
THE ADAPTATION OF COOMASSIE BRILLIANT BLUE R 250 FOR THE RAPID STAINING OF MYELIN AND GLIAL FIBERS (1978) (0)
MYOCARDIAL “CORE-LIKE” LESIONS IN A CONGENITAL MYOPATHY: 217 (1989) (0)
RNA LOSS IN ALZ‐50 REACTIVE NEURONS IN ALZHEIMER'S DISEASE.: 12 (1987) (0)
Factors associated with cognitive impairment in persons with autopsy Braak stage 4 or greater: Results from the Honolulu-Asia Aging Study (HAAS) (2010) (0)
CADASIL IN A NORTH AMERICAN FAMILY. AUTHORS' REPLY (1999) (0)
Methods and systems for sequential delivery of aqueous compositions (2018) (0)
P4-104: Metabolic dysregulation is associated with the development of mild cognitive impairment and Alzheimer's disease (2008) (0)
Minority Participation in the PREADVISE Trial: Relevant Characteristics (2006) (0)
ULTRASTRUCTURE OF SV40 VIRUS-TRANSFORMED HAMSTER BRAIN CELLS IN VITRO: 86 (1982) (0)
Neuropathological diagnosis of alzheimer ' s disease : the relationship between postmortem assessment , cognitive function and functional status in (2013) (0)
Reply (1982) (0)
Effect of Cf-252 neutron implantation on dog brain (1986) (0)
IC-P-040 Structural image data from normals grouped by six-year cognitive outcome: MCI/AD conversion vs. normal (2006) (0)
AXONAL ALTERATIONS IN THE MYENTERIC PLEXUS OF THE PYLORUS IN INFANTILE HYPERTROPHIC PYLORIC STENOSIS: 20 (1977) (0)
Excessbrainprotein oxidation andenzymedysfunction innormal agingandinAlzheimer disease (1991) (0)
Reply (1993) (0)
Neuronal RNA in relation to neuronal loss and neurofibrillary pathology in the hippocampus in Alzheimerʼs disease (1988) (0)
5-nitro-gamma-tocopherol is a biomarker for nitrative stress in human neurological disease (2000) (0)
Application of electron energy loss spectroscopy and electron spectroscopic imaging to aluminum development in biological tissue (2008) (0)
(cid:1) -Amyloid Mediated Nitration of Manganese Superoxide Dismutase Implication for Oxidative Stress in a APP X PS-1 P264L/P264L Double Knock-In Mouse Model of Alzheimer’s Disease (2006) (0)
Juvenile amaurotic idiocy and lymphocyte inclusions. (1978) (0)
Fatal neonatal nemaline myopathy congenital anomalies with multiple (1979) (0)
P3-007 Cognitive screening in the antioxidant AD prevention (PREADVISE) trial: Concordance of MIS and CERAD (2006) (0)
P4-155: Preclinical Alzheimer's disease in a large autopsy series of longitudinally studied, cognitively normal control subjects (2008) (0)
167 CALMODULIN LEVELS AND CALCIUM STIMULATION OF ADENYLATE CYCLASE IN THE FRONTAL CORTEX OF PATIENTS WITH ALZHEIMERʼS DISEASE (1984) (0)
RECENT DEVELOPMENTS IN THE PATHOLOGY OF BRAIN INJURY DURING HUMAN AND EXPERIMENTAL CARDIOPULMONARY BYPASS (1998) (0)
Speed and memory correlates of digit symbol recall performance in older adults (1997) (0)
SYNAPSE LOSS IN BRODMANN AREA 9 IN ALZHEIMER'S DISEASE PATIENTS: 15 (1987) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With William R. Markesbery?

William R. Markesbery is affiliated with the following schools: